{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:59:43Z","timestamp":1763621983248,"version":"3.45.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>There is considerable potential for using Chinese Herbal Medicine to manage inflammatory co-morbidities, including cardiovascular disease, in people with HIV. However, any use would require understanding herb\u2013drug interactions with antiretroviral (ARV) drugs to ensure safety. We evaluate evidence for the effect of selected cardioprotective Chinese herbs on the activity of cytochrome P450 (CYP) enzymes that metabolise ARV drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a comprehensive review of six Chinese herbs commonly found in Chinese herbal formulas for treating cardiovascular conditions. We examined the effects of their extracts and reference bioactive molecules on CYP expression and enzymatic activity. The review focused on evidence from\n                      <jats:italic>in vitro<\/jats:italic>\n                      laboratory studies. The included herbs were Dan Shen, Huang Qi, Bai Zhu, Dang Gui, Chuan Xiong, and Gan Cao. Study quality was assessed using the SciRAP 2.1 risk of bias tool, and results were grouped according to experimental methodology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>426 articles were identified of which 24 met the inclusion criteria. Overall risk of bias was low. Dan Shen and Gan Cao were the most frequently studied herbs. The most common outcome reported was no significant effect on enzyme activity, occurring in 61% of assays for Dan Shen, 37% for Gan Cao, 47% for Dang Gui, and 67% for Huang Qi. Aqueous extracts, representing the most clinically relevant preparation, of Dan Shen had minimal impact on CYP activity, while those of Gan Cao indicated potential for enzyme inhibition. In contrast, aqueous extracts of the other herbs showed a tendency toward enzyme induction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that there is great potential for use of Chinese herbal medicine in managing inflammatory co-morbidities in people with HIV, but that careful consideration of herb-ARV drug interaction is warranted. While Dan Shen appears relatively safe to use in individuals receiving ARV therapy, caution is warranted for other herbs. We highlight the importance of clinically relevant extraction methods in herb\u2013drug interaction studies. Since individual herbs may have opposing effects on ARV drug metabolism, studies conducted using whole formulae are critical.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1627058","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:20:07Z","timestamp":1763619607000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardioprotective Chinese herbs and antiretroviral drug metabolism: a systematic review of in vitro evidence"],"prefix":"10.3389","volume":"16","author":[{"given":"Wan-Jung","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Jaworowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine M.","family":"Trevillyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna C.","family":"Hearps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlie C.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony L.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/encyclopedia4010014","article-title":"Astragalus membranaceus (huangqi) supplementation in sports training: a systematic review","volume":"4","author":"Antonelli","year":"2024","journal-title":"Encyclopedia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1749-8546-6-29","article-title":"Bioactivities of major constituents isolated from Angelica sinensis (danggui)","volume":"6","author":"Chao","year":"2011","journal-title":"Chin. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/toxsci\/kfad079","article-title":"In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis fisch. Ex DC","volume":"196","author":"Chen","year":"2023","journal-title":"Toxicol. Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijcard.2007.01.004","article-title":"Cardiovascular effects of danshen","volume":"121","author":"Cheng","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"B5","unstructured":"Chinese pharmacopoeia\n          \n          \n          2020"},{"key":"B6","first-page":"1014","article-title":"Transcriptional regulation of cytochrome P450 3A4 by four kinds of traditional Chinese medicines","author":"Dong","year":"2008","journal-title":"China J. Chin. Materia Medica"},{"key":"B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chemico-Biological Interact."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1749-8546-4-5","article-title":"Stimulation of apolipoprotein A-IV expression in Caco-2\/TC7 enterocytes and reduction of triglyceride formation in 3T3-L1 adipocytes by potential anti-obesity Chinese herbal medicines","volume":"4","author":"Guo","year":"2009","journal-title":"Chin. Med."},{"key":"B10","first-page":"1611","article-title":"Metabolism based herb-drug interaction-lipid-lowering herbs and Atorvastatin in vitro","volume":"14","author":"Guo","year":"2014","journal-title":"Prog. Mod. Biomed."},{"key":"B11","first-page":"2340","article-title":"Flavonoids inhibit six cytochrome P450 enzymes from human liver microsomes as analyzed by LC-MS\/MS method","volume":"18","author":"He","year":"2009","journal-title":"Chin. J. New Drugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41569-019-0219-9","article-title":"HIV infection and coronary heart disease: mechanisms and management","volume":"16","author":"Hsue","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cbi.2015.02.006","article-title":"Effects of tanshinones from Salvia miltiorrhiza on CYP2C19 activity in human liver microsomes: enzyme kinetic and molecular docking studies","volume":"230","author":"Hu","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"B14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2133\/dmpk.dmpk-10-rg-115","article-title":"CAR-mediated up-regulation of CYP3A4 expression in LS174T cells by Chinese herbal compounds","volume":"26","author":"Huang","year":"2011","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.3389\/fimmu.2019.01378","article-title":"How monocytes contribute to increased risk of atherosclerosis in virologically-suppressed HIV-Positive individuals receiving combination antiretroviral therapy","volume":"10","author":"Jaworowski","year":"2019","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/antiox9090857","article-title":"Overview of Salvia miltiorrhiza as a potential therapeutic agent for various diseases: an update on efficacy and mechanisms of action","volume":"9","author":"Jung","year":"2020","journal-title":"Antioxidants"},{"key":"B17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jep.2013.07.014","article-title":"Effect of Chinese herbs on CYP3A4 activity and expression in vitro","volume":"149","author":"Lau","year":"2013","journal-title":"J. Ethnopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S52","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: a systematic review","volume":"97","author":"Law","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"B19","first-page":"1","article-title":"The Study on the mechanism of danggui-shaoyao-san improving the bioavailability of ferulic acid","volume":"31","author":"Li","year":"2020","journal-title":"Lishizhen Med. Materia Medica Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"922497","DOI":"10.3389\/fcvm.2022.922497","article-title":"Effects and safety of Chinese herbal medicine on inflammatory biomarkers in cardiovascular diseases: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Li","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"B21","first-page":"57","article-title":"Study on toxicity reduction mechanism of Aconitine combined with ellagic acid and liquiritin based on drug metabolic enzyme","volume":"30","author":"Li","year":"2023","journal-title":"Chin. J. Inf. Traditional Chin. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9781715","DOI":"10.1155\/2016\/9781715","article-title":"Danshen (Salvia miltiorrhiza) compounds improve the biochemical indices of the patients with coronary heart disease","volume":"2016","author":"Liu","year":"2016","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/ijerph13010084","article-title":"In vitro and in vivo inhibitory effects of glycyrrhetinic acid in mice and human cytochrome P450 3A4","volume":"13","author":"Lv","year":"2015","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B24","first-page":"2743","article-title":"Effects of cryptotanshinone and tanshinone\u2161A in Danshen capsules on the activity of cytochrome P450 3A4 in human liver HepG2 cells and the metabolism of clopidogrel","volume":"34","author":"Ma","year":"2018","journal-title":"Chin. J. Clin. Pharmacol."},{"key":"B25","first-page":"2235","article-title":"In vitro herb-drug interaction mediated by CYP3A4 and its potential application in the treatment of AIDS","volume":"21","author":"Mao","year":"2012","journal-title":"Chin. J. New Drugs"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e207954","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/ATV.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arteriosclerosis, thrombosis, Vasc. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/COH.0000000000000701","article-title":"The intersection of drug interactions and adverse reactions in contemporary antiretroviral therapy","volume":"16","author":"Nhean","year":"2021","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0016-5085(89)80077-0","article-title":"Glutathione S-transferase, cytochrome P450, and uridine 5'-diphosphate-glucuronosyltransferase in human small intestine and liver","volume":"96","author":"Peters","year":"1989","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3109\/13880209.2011.576346","article-title":"Ligusticum chuanxiong hort: a review of chemistry and pharmacology","volume":"49","author":"Ran","year":"2011","journal-title":"Pharm. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12889-023-15321-7","article-title":"Prevalence and risk factors of cardiovascular disease among people living with HIV in the Asia-Pacific region: a systematic review","volume":"23","author":"Ruamtawee","year":"2023","journal-title":"BMC Public Health"},{"key":"B33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3109\/00498251003592683","article-title":"Rapid screening of commercially available herbal products for the inhibition of major human hepatic cytochrome P450 enzymes using the N-in-one cocktail","volume":"40","author":"Sevior","year":"2010","journal-title":"Xenobiotica"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1142\/s0192415x13500729","article-title":"Anti-inflammatory effects of danshen on human vascular endothelial cells in culture","volume":"41","author":"Stumpf","year":"2013","journal-title":"Am. J. Chin. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/med.21785","article-title":"Phytochemistry and cardiovascular protective effects of huang-qi (astragali radix)","volume":"41","author":"Su","year":"2021","journal-title":"Med. Res. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3390\/plants10122751","article-title":"Glycyrrhiza glabra (licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology","volume":"10","author":"Wahab","year":"2021","journal-title":"Plants (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.phymed.2011.09.075","article-title":"Investigation of cytochrome P450 1A2 and 3A inhibitory properties of danshen tincture","volume":"19","author":"Wang","year":"2012","journal-title":"Phytomedicine"},{"key":"B38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.phymed.2010.05.003","article-title":"Major tanshinones of danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro","volume":"17","author":"Wang","year":"2010","journal-title":"Phytomedicine"},{"key":"B39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/s1499-3872(11)60085-4","article-title":"Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells","volume":"10","author":"Wang","year":"2011","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbi.2012.08.023","article-title":"Pregnane X receptor mediated-transcription regulation of CYP3A by glycyrrhizin: a possible mechanism for its hepatoprotective property against lithocholic acid-induced injury","volume":"200","author":"Wang","year":"2012","journal-title":"Chemico-Biological Interact."},{"key":"B41","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425255.2012.685237","article-title":"Role of CAR and PXR in xenobiotic sensing and metabolism","volume":"8","author":"Wang","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B42","first-page":"1","article-title":"Effects of cryptotanshinone on CYP3A4 and CYP2C9 expressions","volume":"25","author":"Wang","year":"2015","journal-title":"China J. Mod. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1142\/S0192415X16500324","article-title":"Astragalus saponins inhibits lipopolysaccharide-induced inflammation in mouse macrophages","volume":"44","author":"Wang","year":"2016","journal-title":"Am. J. Chin. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"E66","DOI":"10.1002\/hep.32730","article-title":"Letter to the editor: LO2, a misidentified cell line: some data should be interpreted with caution","volume":"77","author":"Weiskirchen","year":"2023","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1124\/dmd.31.8.1035","article-title":"Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties","volume":"31","author":"Wilkening","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"B46","first-page":"369","article-title":"Transcriptional regulation of cytochrome P450 3A4 through human pregnane X receptor by six monomers of traditional Chinese medicine","volume":"12","author":"Xia","year":"2012","journal-title":"J. Trop. Med."},{"key":"B47","first-page":"619","article-title":"Inhibitory effects of eleven active components of Salvia miltiorrhiza bge. Extract on catalytic activity of cytochrome P450 enzymes in human liver microsomes","volume":"50","author":"Xu","year":"2015","journal-title":"Chin. Pharm. J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"727154","DOI":"10.3389\/fphar.2021.727154","article-title":"A review of the ethnopharmacology, phytochemistry, pharmacology, application, quality control, processing, toxicology, and pharmacokinetics of the dried rhizome of Atractylodes macrocephala","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cbi.2008.08.013","article-title":"PXR-Mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIA","volume":"177","author":"Yu","year":"2009","journal-title":"Chemico-Biological Interact."},{"key":"B50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s13318-012-0102-0","article-title":"Study of the upregulation of the activity of cytochrome P450 3A isoforms by astragalus injection and astragalus granules in rats and in cells","volume":"38","author":"Zhang","year":"2013","journal-title":"Eur. J. Drug Metabolism Pharmacokinet."},{"key":"B51","first-page":"922","article-title":"Inhibition of CYP450 activity by honokiol and other four components of Chinese traditionalmedicine in vitro","volume":"22","author":"Zhang","year":"2017","journal-title":"Chin. J. Clin. Pharmacol. Ther."},{"key":"B52","first-page":"42","article-title":"Activating effect of effective components in medicinal and edible substances on human pregnane X receptor and cytotoxicity screening","volume":"28","author":"Zhang","year":"2022","journal-title":"Chin. J. Exp. Traditional Med. Formulae"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1627058\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T06:20:10Z","timestamp":1763619610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1627058\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":52,"alternative-id":["10.3389\/fphar.2025.1627058"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1627058","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1627058"}}